Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Small ; 10(9): 1790-8, 2014 May 14.
Article in English | MEDLINE | ID: mdl-24510544

ABSTRACT

Efficient and safe delivery systems for siRNA therapeutics remain a challenge. Elevated secreted protein, acidic, and rich in cysteine (SPARC) protein expression is associated with tissue scarring and fibrosis. Here we investigate the feasibility of encapsulating SPARC-siRNA in the bilayers of layer-by-layer (LbL) nanoparticles (NPs) with poly(L-arginine) (ARG) and dextran (DXS) as polyelectrolytes. Cellular binding and uptake of LbL NPs as well as siRNA delivery were studied in FibroGRO cells. siGLO-siRNA and SPARC-siRNA were efficiently coated onto hydroxyapatite nanoparticles. The multilayered NPs were characterized with regard to particle size, zeta potential and surface morphology using dynamic light scattering and transmission electron microscopy. The SPARC-gene silencing and mRNA levels were analyzed using ChemiDOC western blot technique and RT-PCR. The multilayer SPARC-siRNA incorporated nanoparticles are about 200 nm in diameter and are efficiently internalized into FibroGRO cells. Their intracellular fate was also followed by tagging with suitable reporter siRNA as well as with lysotracker dye; confocal microscopy clearly indicates endosomal escape of the particles. Significant (60%) SPARC-gene knock down was achieved by using 0.4 pmole siRNA/µg of LbL NPs in FibroGRO cells and the relative expression of SPARC mRNA reduced significantly (60%) against untreated cells. The cytotoxicity as evaluated by xCelligence real-time cell proliferation and MTT cell assay, indicated that the SPARC-siRNA-loaded LbL NPs are non-toxic. In conclusion, the LbL NP system described provides a promising, safe and efficient delivery platform as a non-viral vector for siRNA delivery that uses biopolymers to enhance the gene knock down efficiency for the development of siRNA therapeutics.


Subject(s)
Gene Silencing , Gene Transfer Techniques , Nanoparticles/chemistry , Osteonectin/genetics , RNA, Small Interfering/metabolism , Endocytosis , Flow Cytometry , Gene Knockdown Techniques , Humans , Intracellular Space/metabolism , Male , Nanoparticles/ultrastructure , Neoplasm Proteins/metabolism , Osteonectin/antagonists & inhibitors , Osteonectin/biosynthesis , Osteonectin/ultrastructure , Particle Size , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , Ribosomal Proteins/metabolism , Static Electricity
2.
Eur J Biochem ; 205(1): 233-40, 1992 Apr 01.
Article in English | MEDLINE | ID: mdl-1555584

ABSTRACT

Reversible binding of calcium ions to a single high-affinity binding site in the 40-kDa basement membrane protein (BM-40) caused a 33% increase of alpha-helicity, an about 60% change in intrinsic fluorescence and a dramatic increase of the rate of cleavage by alpha-chymotrypsin. All these effects exhibited identical dependencies on calcium concentration from which a dissociation constant Kd = 0.6 microM was determined. Calcium release was accompanied by an increase of the frictional ratio in solution but not by denaturation which occurred at about equal guanidine.HCl concentration for both calcium-saturated and calcium-depleted protein (midpoint 1.5 M). The cleavage sites for alpha-chymotrypsin are located in or near to the EF-hand domain IV of calcium-depleted BM-40 (also known as SPARC, i.e. secreted protein acidic and rich in cysteine, and osteonectin). These and other data indicate that binding occurs in the EF-hand domain from which a large conformational change is transmitted. Low-affinity calcium-binding sites in the N-terminal glutamic-acid-rich domain I of BM-40 were identified by human leukocyte elastase which was found to cleave very specifically in the middle of this domain. From the increase of cleavage rate with increasing calcium concentration a Kd greater than or equal to 10 mM was estimated. It is suggested that variations of calcium levels in the extracellular space in this range may regulate functions of BM-40 such as collagen binding and that high-affinity binding is important for stabilization, folding and secretion during biosynthesis.


Subject(s)
Calcium/metabolism , Osteonectin/metabolism , Amino Acid Sequence , Aniline Compounds , Animals , Cations, Divalent , Chymotrypsin/metabolism , Circular Dichroism , Electrophoresis, Polyacrylamide Gel , Hydrolysis , Kinetics , Leukocyte Elastase , Mice , Microscopy, Electron , Molecular Sequence Data , Osteonectin/ultrastructure , Pancreatic Elastase/metabolism , Protein Conformation , Spectrometry, Fluorescence , Substrate Specificity , Ultracentrifugation , Xanthenes
3.
Eur J Biochem ; 198(1): 141-50, 1991 May 23.
Article in English | MEDLINE | ID: mdl-2040276

ABSTRACT

Basement membrane protein BM-40, prepared from the mouse Engelbreth-Holm-Swarm tumor, was used in native, denatured and proteolytically processed form for binding to various extracellular matrix proteins. BM-40 and its derivatives were also characterized by CD spectroscopy, calcium binding and epitope analysis. Of several basement membrane proteins tested only collagen IV showed a distinct and calcium-dependent binding of BM-40 in an immobilized ligand assay. This interaction was specific as shown by a low activity of other collagen types (I, III, V, VI) in direct binding and competition assays. The binding was reduced or abolished by metal-ion-chelating or chaotropic agents, high salt and reduction of disulfide bonds in BM-40. Fragment studies indicated that domains III (alpha-helix) and/or IV (EF hand) of BM-40 possess the binding site(s) for collagen IV, while the N-terminal domains I and II provide the major antigenic determinants. A major BM-40-binding site on collagen IV was dependent on a triple-helical conformation and could be localized to a pepsin fragment from the central portion of the triple-helical domain, in agreement with electron microscopic visualization of BM-40--collagen-IV complexes.


Subject(s)
Basement Membrane/metabolism , Calcium/metabolism , Collagen/metabolism , Osteonectin/metabolism , Amino Acid Sequence , Animals , Binding Sites , Chromatography, Liquid , Circular Dichroism , Collagen/ultrastructure , Electrophoresis, Polyacrylamide Gel , Hydrolysis , Immunoenzyme Techniques , Mice , Microscopy, Electron , Molecular Sequence Data , Osteonectin/ultrastructure , Protein Denaturation , Sarcoma, Experimental/chemistry , Trypsin
SELECTION OF CITATIONS
SEARCH DETAIL
...